HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.

Abstract
Young adults treated with a high potency neuroleptic such as haloperidol are at high risk of developing dystonic reactions. In this retrospective study, 15 of 16 young adult patients treated only with haloperidol had such reactions within 60 hours of beginning the drug, while none of the seven patients treated with haloperidol plus prophylactic benztropine mesylate developed dystonia. Although methodologic considerations limit the generalization of these results, they are consistent with other reports and suggest that initial anticholinergic prophylaxis is warranted in young patients treated with high potency antipsychotics. All dystonic reactions in these patients occurred within 2 1/2 days, justifying the consideration of discontinuing prophylaxis (which also causes side effects) after 1 week.
AuthorsW F Boyer, N H Bakalar, C R Lake
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 7 Issue 3 Pg. 164-6 (Jun 1987) ISSN: 0271-0749 [Print] United States
PMID3597801 (Publication Type: Journal Article)
Chemical References
  • Parasympatholytics
  • Tropanes
  • Benztropine
  • Haloperidol
Topics
  • Acute Disease
  • Adult
  • Benztropine (administration & dosage, analogs & derivatives, therapeutic use)
  • Drug Therapy, Combination
  • Dystonia (chemically induced, prevention & control)
  • Female
  • Haloperidol (administration & dosage, adverse effects)
  • Humans
  • Male
  • Parasympatholytics (administration & dosage, therapeutic use)
  • Psychotic Disorders (drug therapy)
  • Retrospective Studies
  • Tropanes (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: